Defining and characterising diabetic ketoacidosis in adults
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
AIMS Diabetic ketoacidosis (DKA) remains one of the most frequently encountered diabetes related emergencies, and despite updates in management and increasing standardisation of care, still has an appreciable morbidity and mortality. This review focusses on the pathophysiology and epidemiology of DKA, but also on the importance of having a standardised definition. METHODS Relevant data were reviewed where there was available basic science or clinical papers published in peer-reviewed international journals on DKA. These included consensus documents and national or international guidelines RESULTS: The prevalence of DKA varies around the world, but part of this could be down to the way the condition is defined. Examples of this difference include the recent studies on sodium glucose co-transporter inhibitors in people with type 1 and type 2 diabetes which have all been associated with increased rates of DKA, but have highlighted how differences in definitions can make comparisons between agents very difficult. CONCLUSIONS DKA should only be diagnosed when all three components are present - the 'D', the 'K' and the 'A'. In addition, the definitions used to diagnose DKA should be standardised - in particular for clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062 · cited 8×
“The dapagliflozin studies used the ADA guideline [41] “but without the requirement for hyperglycaemia” [58].”
BackgroundMethodInfluentialState of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Peters, A. L., Buschur, E. O., Buse, J. B., Cohan, P., Diner, J. C., & Hirsch, I. B. (2015) · Diabetes Care · doi:10.2337/dc15-0843 · Cited by 849
Rosenstock, J., & Ferrannini, E. (2015) · Diabetes Care · doi:10.2337/dc15-1380 · Cited by 664 · cited 1×
“There are data to suggest that renal glucose clearance is higher in this condition than with hyperglycaemic DKA [55].”
BackgroundDiabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563 · cited 1×
“pump malfunction or faulty injection device [5,6].”
Stentz, F. B., Umpierrez, G. E., Cuervo, R., & Kitabchi, A. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2079 · Cited by 497 · cited 1×
“These ketone bodies enter the circulation primarily as β-hydroxybutyrate (which is, strictly speaking, a hydroxyl acid but referred to from here on as a ketone body) and acetoacetate at an approximate ratio of 10:1 [4].”
BackgroundEffects of sotagliflozin added to insulin in patients with type 1 diabetes
Garg, S. K., Henry, R. R., Banks, P., Buse, J. B., Davies, M. J., Fulcher, G. R., Pozzilli, P., Gesty-Palmer, D., Lapuerta, P., Simó, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708337 · Cited by 417
Agiostratidou, G., Anhalt, H., Ball, D., Blonde, L., Gourgari, E., Harriman, K. N., Kowalski, A. J., Madden, P., McAuliffe-Fogarty, A. H., McElwee-Malloy, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1624 · Cited by 397
Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
Rosenstock, J., Marquard, J., Laffel, L. M., Neubacher, D., Kaspers, S., Cherney, D. Z., Zinman, B., Skyler, J. S., George, J., Soleymanlou, N., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1749 · Cited by 363
The metabolic derangements and treatment of diabetic ketoacidosis
Flier, J. S., Moore, M. J., Foster, D. W., & McGarry, J. D. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307213090307 · Cited by 318
Narrative Review: Ketosis-Prone Type 2 Diabetes Mellitus
Umpierrez, G. E., Smiley, D., & Kitabchi, A. E. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00011 · Cited by 299 · cited 1×
“Most cases occur in those with type 1 diabetes, but in some regions DKA in people type 2 diabetes accounts for up to 50% of cases, depending on family history and ethnicity [7,8].”
BackgroundKetoacidosis associated with SGLT2 inhibitor treatment: analysis of FAERS data
Blau, J. E., Tella, S. H., Taylor, S. I., & Rother, K. I. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2924 · Cited by 271 · cited 2×
“Therefore these criteria clearly need revising [45-48].”
BackgroundMathieu, C., Dandona, P., Gillard, P., Senior, P., Hasslacher, C., Araki, E., Lind, M., Bain, S. C., Jabbour, S., Arya, N., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0623 · Cited by 252 · cited 1×
“The dapagliflozin studies used the ADA guideline [41] “but without the requirement for hyperglycaemia” [58].”
MethodDandona, P., Mathieu, C., Phillip, M., Hansen, L., Tschöpe, D., Thorén, F., Xu, J., Langkilde, A. M., DEPICT-1 Investigators, Proietto, J., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1087 · Cited by 243 · cited 3×
“Therefore these criteria clearly need revising [45-48].”
BackgroundBuse, J. B., Garg, S. K., Rosenstock, J., Bailey, T. S., Banks, P., Bode, B. W., Danne, T., Kushner, J. A., Lane, W. S., Lapuerta, P., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0343 · Cited by 234 · cited 1×
“This makes direct comparison of DKA incidence rates between agents impossible [47,57,60,61].”
BackgroundTreatment of diabetic ketoacidosis with subcutaneous insulin aspart
Umpierrez, G. E., Cuervo, R., Karabell, A., Latif, K., Freire, A. X., & Kitabchi, A. E. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1873 · Cited by 227
Desai, D., Mehta, D., Mathias, P., Menon, G., & Schubart, U. K. (2018) · Diabetes Care · doi:10.2337/dc17-1379 · Cited by 206
Zhong, V. W., Juhaeri, J., & Mayer-Davis, E. J. (2018) · Diabetes Care · doi:10.2337/dc17-1583 · Cited by 177 · cited 1×
“rates of hospital admission with DKA have risen between 1997 and 2013 [27].”
BackgroundEuglycemic diabetic ketoacidosis
Barski, L., Eshkoli, T., Brandstaetter, E., & Jotkowitz, A. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.03.014 · Cited by 176
Risk of death following admission to a UK hospital with diabetic ketoacidosis
Gibb, F. W., Teoh, W. L., Graham, J., & Lockman, K. A. (2016) · Diabetologia · doi:10.1007/s00125-016-4034-0 · Cited by 170 · cited 1×
“4% whilst in the UK, mortality has also been reported at <1% [6,22,31,32].”
BackgroundKarges, B., Rosenbauer, J., Holterhus, P.-M., Beyer, P., Seithe, H., Vogel, C., Böckmann, A., Peters, D., Müther, S., Neu, A., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0129 · Cited by 129
Mays, J. A., Jackson, K. L., Derby, T. A., Behrens, J. J., Goel, S., Molitch, M. E., Kho, A. N., & Wallia, A. (2016) · Diabetes Care · doi:10.2337/dc16-0668 · Cited by 95
Incidence of diabetic ketoacidosis at diagnosis of type 1 diabetes in Colorado youth, 1998-2012
Rewers, A., Dong, F., Slover, R. H., Klingensmith, G. J., & Rewers, M. (2015) · JAMA · doi:10.1001/jama.2015.1414 · Cited by 92
Kalscheuer, H., Seufert, J., Lanzinger, S., Rosenbauer, J., Karges, W., Bergis, D., Mader, J. K., Zimny, S., Schmid, S. M., Hummel, M., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1160 · Cited by 40 · cited 1×
“However, more recent data from Germany suggests that overall rates have decreased slightly to 25 per 1000 patient years, with the highest rates in those aged 18-30 years old [28].”
Background
Cited by
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0165-1 · Cited by 461
Self-citationHyperglycemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0032 · Cited by 278
Self-citationEhrmann, D., Kulzer, B., Roos, T., Haak, T., Al-Khatib, M., & Hermanns, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30042-5 · Cited by 141
Controversies around the measurement of blood ketones to diagnose and manage diabetic ketoacidosis
Kilpatrick, E. S., Butler, A. E., Ostlundh, L., Atkin, S. L., & Sacks, D. B. (2022) · Diabetes Care · doi:10.2337/dc21-2279 · Cited by 41
O’Reilly, J. E., Jeyam, A., Caparrotta, T. M., Mellor, J., Hohn, A., McKeigue, P. M., McGurnaghan, S. J., Blackbourn, L. A. K., McCrimmon, R., Wild, S. H., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0689 · Cited by 25
Metadata
- Authors
- Dhatariya, K. K.
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 155
- Pages
- 107797
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2962815603
- Cited by
- 93
- References
- 24
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.